ImmuPharma plc (LON:IMM – Get Free Report) was up 13% on Wednesday . The company traded as high as GBX 10.80 and last traded at GBX 10.47. Approximately 5,669,329 shares changed hands during mid-day trading, a decline of 30% from the average daily volume of 8,065,854 shares. The stock had previously closed at GBX 9.26.
ImmuPharma Trading Up 13.4%
The firm has a fifty day simple moving average of GBX 10.98 and a two-hundred day simple moving average of GBX 5.43. The stock has a market cap of £52.79 million, a PE ratio of -11.80 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Featured Stories
- Five stocks we like better than ImmuPharma
- How to trade penny stocks: A step-by-step guide
- Is Qualcomm Up 40% or Down 20%? 2 Contrarian Takes
- What is the MACD Indicator and How to Use it in Your Trading
- Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast
- How to Buy Cheap Stocks Step by Step
- Rocket Lab Stock Jumps After Earnings, Despite Neutron Delay
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
